Loading…
Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study
Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging. We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people. This population-based study included 3363 participants (age≥60...
Saved in:
| Published in: | PloS one 2015-03, Vol.10 (3), p.e0119582-e0119582 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c767t-cd2f0813f59251d0cfee318837190ceee75324d0414b754c76f6ea58b4b402e3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c767t-cd2f0813f59251d0cfee318837190ceee75324d0414b754c76f6ea58b4b402e3 |
| container_end_page | e0119582 |
| container_issue | 3 |
| container_start_page | e0119582 |
| container_title | PloS one |
| container_volume | 10 |
| creator | Wang, Rui Fratiglioni, Laura Liang, Yajun Welmer, Anna-Karin Xu, Weili Mangialasche, Francesca Johnell, Kristina Qiu, Chengxuan |
| description | Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging.
We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people.
This population-based study included 3363 participants (age≥60 years, 64.9% women) in the Swedish National study on Aging and Care in Kungsholmen, in central Stockholm, Sweden (2001-2004). Data on demographics, cardiometabolic risk factors (hypertension, obesity, diabetes, and high cholesterol), and medication use were collected through face-to-face interviews, clinical examinations, laboratory tests, and the inpatient register. Cardiometabolic risk factors were defined following the most commonly used criteria. Prevalence was standardized using local census data.
The age- and sex-standardized prevalence of diabetes, obesity, high cholesterol, and hypertension was 9.5%, 12.8%, 49.7%, and 74.9%, respectively. The prevalence of hypertension and diabetes increased with age, whereas the prevalence of obesity and high cholesterol decreased with age. Forty-nine percent of older adults had two or more cardiometabolic risk factors; 9.8% had three or more. Overall, 55.5% of people with hypertension, 50.3% with diabetes, and 25.0% with high cholesterol received pharmacological treatment. Of those treated pharmacologically, 49.4%, 38.1%, and 85.5% reached therapeutic goals for hypertension (blood pressure |
| doi_str_mv | 10.1371/journal.pone.0119582 |
| format | article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1667181140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A422548238</galeid><doaj_id>oai_doaj_org_article_83e2f6ec84f34b2a94314b6fae02afa0</doaj_id><sourcerecordid>A422548238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c767t-cd2f0813f59251d0cfee318837190ceee75324d0414b754c76f6ea58b4b402e3</originalsourceid><addsrcrecordid>eNqNk21r1TAUx4sobk6_gWhAEIXda5765AthzKfBYOLG3oY0Pb03W9rUJJ3ue_iBTe_txioTpC8aTn___yH_npMkzwleEpaTdxd2cJ00y952sMSElGlBHyS7pGR0kVHMHt457yRPvL_AOGVFlj1Odmial2WK6W7y-5uDK2mgU7CP-rV0rVTW2JVW0qDgQIYWurCPZFcjZbvgrEG2QUq6WtsWgqys0Qo57S9RI1WwziPZ2m6FrKnBoR5sbwDpDqno46LpabDqcm1N-x5J1Nt-MDJo2y0q6aFGPgz19dPkUSONh2fTey85-_zp7PDr4vjky9HhwfFC5VkeFqqmDS4Ia9KSpqTGqgFgpChiOiVWAJCnjPIac8KrPOVR1GQg06LiFccU2F7ycmvbG-vFlKcXJMtyUhDCcSSOtkRt5YXonW6luxZWarEpWLcS0gWtDIiCAY32quAN4xWVJWexbdZIwFQ2cvRabL38T-iHauY2lS7jCURKeIGzyO__k_-ozw823f0gCMnKkkb8w3SZoWqhntKeqeZfOr0WK3slOMtxvG80eDMZOPtjAB9Eq70CY2QHdtjEkuWUl2S8yqu_0PvDm6hVnC-hu8bGvmo0FQec0pQXlI1tl_dQ8amh1XHioNGxPhO8nQnGqYRfYSUH78XR6ff_Z0_O5-zrO-wapAlrb80wDqefg3wLKme9d9DchkywGFfzJg0xrqaYVjPKXtz9Qbeim11kfwCPRjb8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1667181140</pqid></control><display><type>article</type><title>Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study</title><source>Open Access: PubMed Central</source><source>Publicly Available Content (ProQuest)</source><creator>Wang, Rui ; Fratiglioni, Laura ; Liang, Yajun ; Welmer, Anna-Karin ; Xu, Weili ; Mangialasche, Francesca ; Johnell, Kristina ; Qiu, Chengxuan</creator><contributor>Icks, Andrea</contributor><creatorcontrib>Wang, Rui ; Fratiglioni, Laura ; Liang, Yajun ; Welmer, Anna-Karin ; Xu, Weili ; Mangialasche, Francesca ; Johnell, Kristina ; Qiu, Chengxuan ; Icks, Andrea</creatorcontrib><description>Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging.
We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people.
This population-based study included 3363 participants (age≥60 years, 64.9% women) in the Swedish National study on Aging and Care in Kungsholmen, in central Stockholm, Sweden (2001-2004). Data on demographics, cardiometabolic risk factors (hypertension, obesity, diabetes, and high cholesterol), and medication use were collected through face-to-face interviews, clinical examinations, laboratory tests, and the inpatient register. Cardiometabolic risk factors were defined following the most commonly used criteria. Prevalence was standardized using local census data.
The age- and sex-standardized prevalence of diabetes, obesity, high cholesterol, and hypertension was 9.5%, 12.8%, 49.7%, and 74.9%, respectively. The prevalence of hypertension and diabetes increased with age, whereas the prevalence of obesity and high cholesterol decreased with age. Forty-nine percent of older adults had two or more cardiometabolic risk factors; 9.8% had three or more. Overall, 55.5% of people with hypertension, 50.3% with diabetes, and 25.0% with high cholesterol received pharmacological treatment. Of those treated pharmacologically, 49.4%, 38.1%, and 85.5% reached therapeutic goals for hypertension (blood pressure<150/90 mmHg), diabetes (glycated haemoglobin<7%), and high cholesterol (total cholesterol<6.22 mmol/l), respectively.
Hypertension, high cholesterol, and clustering of cardiometabolic risk factors were common among older people in Stockholm, but pharmacological treatment and control of these major factors can be improved. Appropriate management of cardiometabolic profiles among older people may help improve cardiovascular health and achieve healthy aging.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0119582</identifier><identifier>PMID: 25799502</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Activities of daily living ; Adult ; Adults ; Age ; Age Factors ; Aged ; Aged, 80 and over ; Aging ; Blood Glucose - analysis ; Blood pressure ; Body Mass Index ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - pathology ; Cardiovascular Diseases - prevention & control ; Cholesterol ; Cholesterol, HDL - analysis ; Cholesterol, LDL - analysis ; Clustering ; Demographics ; Demography ; Diabetes mellitus ; Diabetes Mellitus - drug therapy ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - physiopathology ; Drug therapy ; Drugs ; Female ; Gerontology ; Glucose ; Glycated Hemoglobin A - analysis ; Health risk assessment ; Health risks ; Heart diseases ; Hemoglobin ; Humans ; Hypercholesterolemia - complications ; Hypercholesterolemia - drug therapy ; Hypercholesterolemia - epidemiology ; Hypertension ; Hypertension - complications ; Hypertension - drug therapy ; Hypertension - epidemiology ; Laboratory tests ; Male ; Medical research ; Middle Aged ; Obesity ; Obesity - complications ; Obesity - drug therapy ; Obesity - epidemiology ; Older people ; Pharmacology ; Population studies ; Population-based studies ; Prevalence ; Prevalence studies (Epidemiology) ; Risk analysis ; Risk Factors ; Risk management ; Sex Factors ; Studies ; Sweden - epidemiology ; Triglycerides - analysis</subject><ispartof>PloS one, 2015-03, Vol.10 (3), p.e0119582-e0119582</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Wang et al 2015 Wang et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c767t-cd2f0813f59251d0cfee318837190ceee75324d0414b754c76f6ea58b4b402e3</citedby><cites>FETCH-LOGICAL-c767t-cd2f0813f59251d0cfee318837190ceee75324d0414b754c76f6ea58b4b402e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1667181140/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1667181140?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25744,27915,27916,37003,37004,44581,53782,53784,74887</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25799502$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-116992$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:131046045$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><contributor>Icks, Andrea</contributor><creatorcontrib>Wang, Rui</creatorcontrib><creatorcontrib>Fratiglioni, Laura</creatorcontrib><creatorcontrib>Liang, Yajun</creatorcontrib><creatorcontrib>Welmer, Anna-Karin</creatorcontrib><creatorcontrib>Xu, Weili</creatorcontrib><creatorcontrib>Mangialasche, Francesca</creatorcontrib><creatorcontrib>Johnell, Kristina</creatorcontrib><creatorcontrib>Qiu, Chengxuan</creatorcontrib><title>Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging.
We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people.
This population-based study included 3363 participants (age≥60 years, 64.9% women) in the Swedish National study on Aging and Care in Kungsholmen, in central Stockholm, Sweden (2001-2004). Data on demographics, cardiometabolic risk factors (hypertension, obesity, diabetes, and high cholesterol), and medication use were collected through face-to-face interviews, clinical examinations, laboratory tests, and the inpatient register. Cardiometabolic risk factors were defined following the most commonly used criteria. Prevalence was standardized using local census data.
The age- and sex-standardized prevalence of diabetes, obesity, high cholesterol, and hypertension was 9.5%, 12.8%, 49.7%, and 74.9%, respectively. The prevalence of hypertension and diabetes increased with age, whereas the prevalence of obesity and high cholesterol decreased with age. Forty-nine percent of older adults had two or more cardiometabolic risk factors; 9.8% had three or more. Overall, 55.5% of people with hypertension, 50.3% with diabetes, and 25.0% with high cholesterol received pharmacological treatment. Of those treated pharmacologically, 49.4%, 38.1%, and 85.5% reached therapeutic goals for hypertension (blood pressure<150/90 mmHg), diabetes (glycated haemoglobin<7%), and high cholesterol (total cholesterol<6.22 mmol/l), respectively.
Hypertension, high cholesterol, and clustering of cardiometabolic risk factors were common among older people in Stockholm, but pharmacological treatment and control of these major factors can be improved. Appropriate management of cardiometabolic profiles among older people may help improve cardiovascular health and achieve healthy aging.</description><subject>Activities of daily living</subject><subject>Adult</subject><subject>Adults</subject><subject>Age</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging</subject><subject>Blood Glucose - analysis</subject><subject>Blood pressure</subject><subject>Body Mass Index</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cardiovascular Diseases - pathology</subject><subject>Cardiovascular Diseases - prevention & control</subject><subject>Cholesterol</subject><subject>Cholesterol, HDL - analysis</subject><subject>Cholesterol, LDL - analysis</subject><subject>Clustering</subject><subject>Demographics</subject><subject>Demography</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - drug therapy</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - physiopathology</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Female</subject><subject>Gerontology</subject><subject>Glucose</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Health risk assessment</subject><subject>Health risks</subject><subject>Heart diseases</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Hypercholesterolemia - complications</subject><subject>Hypercholesterolemia - drug therapy</subject><subject>Hypercholesterolemia - epidemiology</subject><subject>Hypertension</subject><subject>Hypertension - complications</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Laboratory tests</subject><subject>Male</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Obesity - complications</subject><subject>Obesity - drug therapy</subject><subject>Obesity - epidemiology</subject><subject>Older people</subject><subject>Pharmacology</subject><subject>Population studies</subject><subject>Population-based studies</subject><subject>Prevalence</subject><subject>Prevalence studies (Epidemiology)</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Risk management</subject><subject>Sex Factors</subject><subject>Studies</subject><subject>Sweden - epidemiology</subject><subject>Triglycerides - analysis</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk21r1TAUx4sobk6_gWhAEIXda5765AthzKfBYOLG3oY0Pb03W9rUJJ3ue_iBTe_txioTpC8aTn___yH_npMkzwleEpaTdxd2cJ00y952sMSElGlBHyS7pGR0kVHMHt457yRPvL_AOGVFlj1Odmial2WK6W7y-5uDK2mgU7CP-rV0rVTW2JVW0qDgQIYWurCPZFcjZbvgrEG2QUq6WtsWgqys0Qo57S9RI1WwziPZ2m6FrKnBoR5sbwDpDqno46LpabDqcm1N-x5J1Nt-MDJo2y0q6aFGPgz19dPkUSONh2fTey85-_zp7PDr4vjky9HhwfFC5VkeFqqmDS4Ia9KSpqTGqgFgpChiOiVWAJCnjPIac8KrPOVR1GQg06LiFccU2F7ycmvbG-vFlKcXJMtyUhDCcSSOtkRt5YXonW6luxZWarEpWLcS0gWtDIiCAY32quAN4xWVJWexbdZIwFQ2cvRabL38T-iHauY2lS7jCURKeIGzyO__k_-ozw823f0gCMnKkkb8w3SZoWqhntKeqeZfOr0WK3slOMtxvG80eDMZOPtjAB9Eq70CY2QHdtjEkuWUl2S8yqu_0PvDm6hVnC-hu8bGvmo0FQec0pQXlI1tl_dQ8amh1XHioNGxPhO8nQnGqYRfYSUH78XR6ff_Z0_O5-zrO-wapAlrb80wDqefg3wLKme9d9DchkywGFfzJg0xrqaYVjPKXtz9Qbeim11kfwCPRjb8</recordid><startdate>20150323</startdate><enddate>20150323</enddate><creator>Wang, Rui</creator><creator>Fratiglioni, Laura</creator><creator>Liang, Yajun</creator><creator>Welmer, Anna-Karin</creator><creator>Xu, Weili</creator><creator>Mangialasche, Francesca</creator><creator>Johnell, Kristina</creator><creator>Qiu, Chengxuan</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>ABAVF</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DG7</scope><scope>ZZAVC</scope><scope>DOA</scope></search><sort><creationdate>20150323</creationdate><title>Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study</title><author>Wang, Rui ; Fratiglioni, Laura ; Liang, Yajun ; Welmer, Anna-Karin ; Xu, Weili ; Mangialasche, Francesca ; Johnell, Kristina ; Qiu, Chengxuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c767t-cd2f0813f59251d0cfee318837190ceee75324d0414b754c76f6ea58b4b402e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Activities of daily living</topic><topic>Adult</topic><topic>Adults</topic><topic>Age</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging</topic><topic>Blood Glucose - analysis</topic><topic>Blood pressure</topic><topic>Body Mass Index</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cardiovascular Diseases - pathology</topic><topic>Cardiovascular Diseases - prevention & control</topic><topic>Cholesterol</topic><topic>Cholesterol, HDL - analysis</topic><topic>Cholesterol, LDL - analysis</topic><topic>Clustering</topic><topic>Demographics</topic><topic>Demography</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - drug therapy</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - physiopathology</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Female</topic><topic>Gerontology</topic><topic>Glucose</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Health risk assessment</topic><topic>Health risks</topic><topic>Heart diseases</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Hypercholesterolemia - complications</topic><topic>Hypercholesterolemia - drug therapy</topic><topic>Hypercholesterolemia - epidemiology</topic><topic>Hypertension</topic><topic>Hypertension - complications</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Laboratory tests</topic><topic>Male</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Obesity - complications</topic><topic>Obesity - drug therapy</topic><topic>Obesity - epidemiology</topic><topic>Older people</topic><topic>Pharmacology</topic><topic>Population studies</topic><topic>Population-based studies</topic><topic>Prevalence</topic><topic>Prevalence studies (Epidemiology)</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Risk management</topic><topic>Sex Factors</topic><topic>Studies</topic><topic>Sweden - epidemiology</topic><topic>Triglycerides - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Rui</creatorcontrib><creatorcontrib>Fratiglioni, Laura</creatorcontrib><creatorcontrib>Liang, Yajun</creatorcontrib><creatorcontrib>Welmer, Anna-Karin</creatorcontrib><creatorcontrib>Xu, Weili</creatorcontrib><creatorcontrib>Mangialasche, Francesca</creatorcontrib><creatorcontrib>Johnell, Kristina</creatorcontrib><creatorcontrib>Qiu, Chengxuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale in Context : Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Stockholms universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Stockholms universitet</collection><collection>SwePub Articles full text</collection><collection>Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Rui</au><au>Fratiglioni, Laura</au><au>Liang, Yajun</au><au>Welmer, Anna-Karin</au><au>Xu, Weili</au><au>Mangialasche, Francesca</au><au>Johnell, Kristina</au><au>Qiu, Chengxuan</au><au>Icks, Andrea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-03-23</date><risdate>2015</risdate><volume>10</volume><issue>3</issue><spage>e0119582</spage><epage>e0119582</epage><pages>e0119582-e0119582</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging.
We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people.
This population-based study included 3363 participants (age≥60 years, 64.9% women) in the Swedish National study on Aging and Care in Kungsholmen, in central Stockholm, Sweden (2001-2004). Data on demographics, cardiometabolic risk factors (hypertension, obesity, diabetes, and high cholesterol), and medication use were collected through face-to-face interviews, clinical examinations, laboratory tests, and the inpatient register. Cardiometabolic risk factors were defined following the most commonly used criteria. Prevalence was standardized using local census data.
The age- and sex-standardized prevalence of diabetes, obesity, high cholesterol, and hypertension was 9.5%, 12.8%, 49.7%, and 74.9%, respectively. The prevalence of hypertension and diabetes increased with age, whereas the prevalence of obesity and high cholesterol decreased with age. Forty-nine percent of older adults had two or more cardiometabolic risk factors; 9.8% had three or more. Overall, 55.5% of people with hypertension, 50.3% with diabetes, and 25.0% with high cholesterol received pharmacological treatment. Of those treated pharmacologically, 49.4%, 38.1%, and 85.5% reached therapeutic goals for hypertension (blood pressure<150/90 mmHg), diabetes (glycated haemoglobin<7%), and high cholesterol (total cholesterol<6.22 mmol/l), respectively.
Hypertension, high cholesterol, and clustering of cardiometabolic risk factors were common among older people in Stockholm, but pharmacological treatment and control of these major factors can be improved. Appropriate management of cardiometabolic profiles among older people may help improve cardiovascular health and achieve healthy aging.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25799502</pmid><doi>10.1371/journal.pone.0119582</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2015-03, Vol.10 (3), p.e0119582-e0119582 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_1667181140 |
| source | Open Access: PubMed Central; Publicly Available Content (ProQuest) |
| subjects | Activities of daily living Adult Adults Age Age Factors Aged Aged, 80 and over Aging Blood Glucose - analysis Blood pressure Body Mass Index Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - epidemiology Cardiovascular Diseases - etiology Cardiovascular Diseases - pathology Cardiovascular Diseases - prevention & control Cholesterol Cholesterol, HDL - analysis Cholesterol, LDL - analysis Clustering Demographics Demography Diabetes mellitus Diabetes Mellitus - drug therapy Diabetes Mellitus - epidemiology Diabetes Mellitus - physiopathology Drug therapy Drugs Female Gerontology Glucose Glycated Hemoglobin A - analysis Health risk assessment Health risks Heart diseases Hemoglobin Humans Hypercholesterolemia - complications Hypercholesterolemia - drug therapy Hypercholesterolemia - epidemiology Hypertension Hypertension - complications Hypertension - drug therapy Hypertension - epidemiology Laboratory tests Male Medical research Middle Aged Obesity Obesity - complications Obesity - drug therapy Obesity - epidemiology Older people Pharmacology Population studies Population-based studies Prevalence Prevalence studies (Epidemiology) Risk analysis Risk Factors Risk management Sex Factors Studies Sweden - epidemiology Triglycerides - analysis |
| title | Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T23%3A48%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence,%20pharmacological%20treatment,%20and%20control%20of%20cardiometabolic%20risk%20factors%20among%20older%20people%20in%20central%20Stockholm:%20a%20population-based%20study&rft.jtitle=PloS%20one&rft.au=Wang,%20Rui&rft.date=2015-03-23&rft.volume=10&rft.issue=3&rft.spage=e0119582&rft.epage=e0119582&rft.pages=e0119582-e0119582&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0119582&rft_dat=%3Cgale_plos_%3EA422548238%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c767t-cd2f0813f59251d0cfee318837190ceee75324d0414b754c76f6ea58b4b402e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1667181140&rft_id=info:pmid/25799502&rft_galeid=A422548238&rfr_iscdi=true |